Health · Healthcare & Policy · 2 hrs ago
Beijing health plan adds 17 specialty drugs for 2027
Enrollment has opened for Beijing’s 2027 Huimin Health Insurance plan, a government-supervised commercial supplement to basic medical insurance.
The new year’s plan adds 17 specialty drugs, including treatments for lung cancer, myelofibrosis and chronic obstructive pulmonary disease.
It now covers 165 specialty drugs across 94 diseases, including some high-cost treatments that can cost more than 1 million yuan per course.
For these drugs, patients can be reimbursed for 35% or 65% of costs, depending on whether they had the relevant condition when they joined, up to a 500,000-yuan limit.
Unlike other covered expenses, specialty drugs have no deductible, and the plan also covers some costs left over after basic insurance.
The plan is open to eligible Beijing residents and basic-insurance members, with no age, household-registration, job or health-status restrictions; enrollment has grown steadily over five years.
Enrollment opened on Nov. 4 for the 2027 Beijing Inclusive Health Insurance plan, which adds 17 specialty drugs to its coverage.
The plan now covers 165 specialty drugs for 94 conditions, including lung cancer, myelofibrosis and chronic obstructive pulmonary disease.
For covered specialty drugs, reimbursement is 35% or 65%, depending on the insured person’s health status when joining, up to a limit of 500,000 yuan.
The plan has no deductible for specialty drugs, although other covered expenses are subject to deductibles ranging from 5,000 to 30,404 yuan.
Participation has exceeded 19.8 million enrollments over the plan’s five years, and more than 740,000 claims have been paid.
- Who
- Beijing residents and other eligible people covered by Beijing’s basic medical insurance, including some new residents with a Beijing residence permit and insurance elsewhere.
- What
- The 2027 plan adds 17 specialty drugs, bringing its covered total to 165.
- When
- Enrollment opened on Nov. 4, 2026, for the 2027 insurance year.
- Where
- Beijing, China.
- Why
- The plan is intended to supplement basic medical insurance and reduce patients’ medical costs.
This story does not have two clearly opposing sides.
Enrollment in the plan grew steadily, surpassing 19.8 million enrollments in total.
Enrollment opened for the 2027 insurance year, with 17 specialty drugs added to coverage.
- New drugs
- 17 specialty drugs
- Covered drugs
- 165 domestic and overseas specialty drugs
- Conditions covered
- 94
- Reimbursement ceiling
- 500,000 yuan for specialty drugs
- Cumulative enrollment
- More than 19.8 million enrollments
- Claims paid
- More than 740,000 claims